Oppenheimer Raises Endologix Target from $10 to $11

June 2, 2011 7:36 AM | 8 seconds read |
Oppenheimer is raising its PT on shares of Endologix Inc. ELGX from $10 to $11. Endologix closed Wednesday at $8.30.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetAnalyst RatingsendologixHealth CareHealth Care SuppliesOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!